BCTX
#4431
BriaCell Therapeutics Corp. - Common Shares
3.7 6 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.35%
Monthly Change
+3.87%
6 month change
0.00%
Year Change
-49.05%
Previous Close
3.7 1
Open
3.7 5
Low
3.7 1
High
3.7 6
Volume
127
Financials
- Market Capitalization 32.71 M
- Employee 4
- Founded 2006
- CEO N/A
- Website www.briacell.com
- Headquarter British Columbia, Canada
- FIGI BBG0018783B6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.12
Price to sales ratio
-126.49
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4418 |  IGC IGC Pharma, Inc. Common Stock | 0.32 USD | -3.03% | +6.67% | +23.08% | +24.90% | 33.08 M USD | ||
| 4425 |  KYNB Kyntra Bio, Inc. - Common Stock | 8.02 USD | +0.25% | +7.08% | +15.56% | -15.67% | 32.47 M USD | ||
| 4443 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.00 USD | -1.96% | -10.71% | +17.65% | -3.85% | 31.44 M USD | ||
| 4449 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.71 USD | -1.39% | -4.05% | -6.58% | -27.55% | 30.88 M USD |
Frequently asked questions about Briacell Therapeutics Corp. Common Shares
What is the Briacell Therapeutics Corp. Common Shares stock price today?
The current price of Briacell Therapeutics Corp. Common Shares (BCTX) is 3.76. Over the past 24 hours, the stock has changed by +1.35%. Follow the BCTX chart for real-time price dynamics.
What is the stock ticker of Briacell Therapeutics Corp. Common Shares?
Briacell Therapeutics Corp. Common Shares trades under the ticker BCTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Briacell Therapeutics Corp. Common Shares stock going up?
BCTX has changed by -7.62% over the last week, +3.87% over the last month, and -49.05% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Briacell Therapeutics Corp. Common Shares?
Briacell Therapeutics Corp. Common Shares currently has a market capitalization of 32.71 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Briacell Therapeutics Corp. Common Shares earnings last quarter?
Last quarter, Briacell Therapeutics Corp. Common Shares reported earnings of -0.99 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Briacell Therapeutics Corp. Common Shares revenue for the last quarter?
Briacell Therapeutics Corp. Common Shares reported quarterly revenue of -2 619. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Briacell Therapeutics Corp. Common Shares net income for the last quarter?
Briacell Therapeutics Corp. Common Shares reported net income of -7.16 M for the last quarter. The previous quarter showed -7.22 M, which means net income changed by +0.79%.
How many employees does Briacell Therapeutics Corp. Common Shares have?
As of the latest available data, Briacell Therapeutics Corp. Common Shares has 4 employees. Workforce size can provide additional context about the company's scale and operations.
What is Briacell Therapeutics Corp. Common Shares EBITDA?
Briacell Therapeutics Corp. Common Shares EBITDA is -7.59 M, and its EBITDA margin is 289.82 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Briacell Therapeutics Corp. Common Shares stock?
You can buy Briacell Therapeutics Corp. Common Shares (BCTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Briacell Therapeutics Corp. Common Shares stock?
Investing in Briacell Therapeutics Corp. Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BCTX chart and related analysis on metatrader.com as part of your research.